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The pig is widely used as a large animal model for biomedical
research and could be an interesting experimental model for studes of
the hematopoietic system and its response in physiological and
pathological conditions. With the intention of using the pig as a large
animal model in hematopoietic research, a clonal assay in
methylcellulose was developed and standardized for detection of
committed progenitors of the granulocyte-macrophage lineage from
adult pig bone marrow and peripheral blood. Progenitor cells were
stimulated to proliferate and differentiate in vitro by adding pig
leukocyte conditioned medium (LCM) as a source of homologous
growth factors. The number of CFU-GM (Colony Forming Unit -
Granulocyte-Macrophage) directly depended on the concentration of
LCM. Theproliferative rate of CFU-GMprogenitorcells was determined
by the cytosine arabinoside suicide technique. Thepercentage of bone
marrow and peripheral blood CFU-GMcells in Sphase of the cell cycle
was 34.7% and 22.2%, respectively. The data obtained regarding the
number and characteristics of pig bone marrow and peripheral blood
CFU-GMconfirmed that the organization of the pig CFU-GMprogenitor
cell compartment is similar and comparable to that in miniature swine,
other animal species and humans.
Key words: bone marrow, CFU-GM, in vitro, peripheral blood,
pig.
INTRODUCTION
In the past few decades the pig has been widely used as a large animal
model for biomedical research, since, with the exception of non-human primates,
the size and physiology of the pig are more similar to humans in comparison with
other available large animals (Tumbleson & Schook, 1996). Pigs are particularly
used as a model in tissue transplantation research (Guzzetta et al., 1991), and
their immune system has been extensively studied. Defined transplantation
genetics, monoclonal antibodies to major Iymphohematopoietic subsets, defined
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cluster of differentiation (CO) molecules on mature lymphoid and myeloid
(Saalmuller, 1996), and also on immature myeloid cells (Summerfield and
McCullough, 1997), as well as intensified determination of pig cytokines
(Murtaugh, 1994) exist. The pig was also investigated as a potential xenograft
donor (Latinne et al., 1994; Sykes, 1996). Emery has reported the possibility of
inducing transplantation tolerance by bone marrow stem cell retroviral-mediated
gene-transfer on mini-pigs (Emery et al., 1992, 1993, 1994, 1996). Beside
experimental approaches, bone marrow and peripheral blood stem cell
transplantation is an effective therapy for a variety of hematologic, immunologic
and metabolic disorders (Chopra & Goldstone, 1992; Oemirer, et el., 1995;
Gratwohl & Hermans, 1996). Even though a small number of stem cells reside in
peripheral blood (Goodman & Hodgson, 1962; Geissler et el., 1990; Gratwohl et
al., 1995; Ivanovic et al., 1997), successful mobilization of stem cells from bone
marrow to peripheral blood has enabled new possibilities in stem cell
transplantation procedures (Besinger et el., 1995). Although stem cell
transplantation is widely used in clinical practice, numerous aspects of this
procedure are still under investigation (Pless, et aI., 1999) and an increasing
interest for animal models in hematopoietic research is obvious (Srour, et al., 1992;
Scneidkraut, et aI., 1996). Since the use of the pig experimental model has
practical and biological advantages, it could be used as a valuable preclinical
large animal model.
The development and use of in vitro culture methods for characterizing
porcine bone marrow and peripheral blood hematopoietic elements are
necessary for investigation of stem cell transplantation and hematopoietic stem
cell engraftment in the pig experimental model. An assay for determination of bone
marrow and peripheral blood CFU-GM is essential for such studies, as it was
shown that CFU-GM could be used as a valuable parameter for successful
reconstitution of hematopoiesis and both neutrophil and platelet recovery after
stem cell transplantation (Robertson et et., 1992, Gordon, 1993, Takamatsu et el.,
1995).
In this paper standardization of the methodology for pig bone marrow and
peripheral blood CFU-GM progenitor cell growth in c1onogenic assay in vitro,
using a methylcellulose cell-culture system is reported. In addition, the




The experiments were performed on 20 clinically normal industrial breed
pigs of both sexes, between 4 - 6 months old. Blood samples (20ml) were collected
from the jugular vein in sterile tubes with preservative-free sterile heparin (40U/ml).
The animals were stunned and slaughtered. Bone marrow was harvested by direct
surgical curettage from the ossis ishii (symphysis pelvis) (the bodies passed
through a warm water pool - 62°C), and the cells were suspended in lscovezs
Modification of Dulbeccozs Medium (IMOM, GibcoBRL, Life Technologies,
Paisley, Scotland) and constantly mixed for about one hour.
Peripheral blood parameters were determined by standard laboratory
procedures for all samples.
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Separation of peripheral blood and bone marrow mononuclear cells (MNC)
The bone marrow cell suspensions and/or peripheral blood cells were
centrifuged on a Ficoll-natrium metrizoate density gradient (Lymphoprep-
Nycorned, Oslo, Norway) (1.077g/ml), for 35 min at 300 x g. The interface was
harvested and washed twice and resuspended in IMOM before plating. The MNC
count was made using a haemocytometer, and the viability of cells was
determined using the trypan-blue exclusion test.
Preparation of pig leukocyte conditioned medium - LCM
Conditioned medium was prepared from pig peripheral blood leukocytes
separated from heparinised blood using methylcellulose (MC) as a sedimentation
agent. Leukocytes were incubated in a mixture of 1% of phytohaemaglutinin (PHA,
Pharmacia, Sweden), 10og, of fetal calf serum (FCS, Serva Feinbiochemica, New
York, NY, USA) and 1xi 0 cells/rnl in IMOM. After 7 days of incubation at 37°C in
a humidified atmosphere with 5% C02 in air, the cells were centrifuged and the
supernatant was filtered (0,45 urn) and stored at -20°C.
Colony forming assay for granulocyte-macrophage progenitor cells -
CFU-GM
CFU-GM were cultured according to a protocol developed for humans
(Huvidic et ai, 1985), using pig leukocyte-conditioned medium as a source of
colony-stimulating activity. MNC in different concentations (0.25, 0.5 and 1.0 x
10'" cells for bone marrow and 0.5, 1.0 and 1.5 x 10 cells for peripheral blood)
were plated in final mix~ure containing 0.8% methylcellulose (ICN, Costa Mesa,
USA), 20% FCS, 2x10- Mp-mercaptoethanol (ME, Sigma, St Louis, MO, USA)
and different concentrations of LCM (0; 5%; 10%; 20%; 30%) in lMOM. The cultures
were set up in duplicate in 35 mm culture dishes (Spectar, Cacak, Yugoslavia)
and incubated at 37°C in a humidified atmosphere with 5% C02 in air. CFU-GM
derived colonies were counted under an inverted microscope (magnification x 50)
as groups with more than 50 cells. By continuous observation of the number of
colonies in cultures' the most appropriate time for enumerating colonies was
determined as day 14.
The morphological analysis of cells picked from colonies was performed on
cytological smears stained with May-Grunwald-Giemsa.
Determination of CFU-GM progenitor cells in S phase of the cell cycle
To determine the proportion of progenitor cells in the S phase of the cell
cycle, a suicide assay with cytosine arabinoside (Ara-C) was performed (Shulman
& Robinson, 1986). Briefly, 5x106 cells were incubated with 40 ~g of Ara-C (Upjohn
Company, Kalamazoo, Michigan, USA) in IMOM with 15% FCS, for one hour in a
volume of 2ml at 37°C in a humidified atmosphere with 5% C02 in air. Cells
incubated under the same conditions without Ara-C were used as a control. The
reduction in colony formation by the cells from samples treated with Ara-C was
proportional to the number of progenitors in ONA synthesis (suicide), i.e.
represented an indirect measure of the proportion of proliferating progenitor cells,
as described earlier (Kovacevic et ai, 2000).
Statistical analysis
Statistical analysis was performed using the Students t-test and data are
presented as mean ± standard error (SEM).
•..__ _. __ __.__ _------------
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RESULTS
"'''''·'nl·''''''.,,1 blood parameter values obtained in the animals used in
were in the physiological range for this (data not
·,c· ..,',,,,,·.I'\' of separated MNC before plating was 9C95 %, lnotcatinq
'!)!c\,'r30 procedure was adequate for good recovery of bone marrow
'Y"""""-':o: blood cells.
(,nl",,,",,,1 conditions for pig bone marrow and peripheral blood CFU-GM
colonies growth were defined by cultivating either various numbers of
fixed concentration of LCM or various concentrations of LCM with a
~J1NC.
Tablet. Dependance of bone marrow and peripheral blood CFU-GM








The data are presented as the mean:±:SEMfor 4·-8 inniptlPI,;,:'jpll'f
determinations. Bone marrow and peripheral blood MNCwore
in rnethylcellulose cultures with 5 % and 10%
the relationship between the number
MNC plated and the number of CFU-GM
lumber of bone marrow CFU-GM colonies (Jmec,ccl was I!th!·;·\;'i\,
number of bone marrow MNC cultured, while the same linearity was
not CFU-GM cultivated from peripheral blood MNC.
seeded with the fixed number of cells and various
of LC:t/! showed that the growth of both bone marrow and
r"" !,""I,~,,·''''; blood CFU-GM colonies was dependent on the LCM concentration
1). In LCM unstimulated cultures only a few CFU-GM colonies were
whue increasing concentrations of LCM elevated the number of
CFU·GM-derived colonies. For bone marrow CFU·GM maximal colony induction
W,JS obtained with 5% LCM, while higher concentrations induced a slight inhibitory
effect on CFU-GM growth. Dose response studies for peripheral blood CFU-GM
colonies indicated that the plateau number for these cells was achieved with 10%
LCM and an inhibitory effect was observed with more than 20% of LCM.
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Figure 1.
LCM concentration (%)
Bone marrow Peripheral blood
--- CFU-GM --+- CFU-GM
Dependence of bone marrow and peripheral blood ~FU-GM colony formation on LCM dose.
Mononuclear cells from pig bone marrow (0.5 x 10 ) and peripheral blood (1 x 106) were
plated in duplicate in methylcellulose cultures with increasing concentrations of pig LCM.
Each point represents the mean ± SEM for 4-8 independent determinations. The plateau
number of bone marrow CFU-GMderived colonies was achieved with 5% LCM (t - test (0%:
5%) p<0.01) and the plateau number of peripheral blood CFU-GM derived colonies was
achieved with 10% LCM (t -test (0%: 5%) p<0.01 and (5%: 10%) p<0.05). With all
subsequent concentrations of LCM the number of colonies did not differ significantly.
The experiments performed in optimal cultivation conditions rl,vealed
176-484 bone marrow CFU-GM derived colonies calculated on 1x1a bone
marrow &ANC and 7.5-55.5 peripheral blood CFU-GM derived colonies calculated
on 1x1a peripheral blood MNC. For comparison of our results obtained in pigs,
with data publlshed for other mammalian species, the related values for bone
marrow and peripheral blood CFU-GM progenitor cells are presented in Table 2.
Table 2. The number of bone marrow and peripheral blood CFU-GM progenitor cells in
man and some animal species
Species CFU-GM /105 CFU-GM /106 References
bone marrow peripheral
cells blood cells
man 70 28.8 Metcalf, 1984a; Standen et aI.,
1980
dog 210 19 - 63 Deladar etaI., 1988; Nothdurft et
al.,1980
rat 104 90.4 :t14.4 Kimura et aI., 1986; lvanovie et
aI., 1997
miniature 62 -187 EmeryetaI., 1996
swine
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The CFU-GM derived colonies from both bone marrow and peripheral blood
MNC on day 14 of culture varied in size, but most of them frequently consisted of
more than several thousand cells (Fig. 2). Clusters, groups of less than 50 cells,
Figure 2. Bone marrow CFU-GM derived colony. Day 14 of incubation (magnification 4 x 10 x 4)
were observed but not counted. Compact, intermediate and dispersed shape
colonies appeared, with greater variability observed in bone marrow CFU-GM than
in peripheral blood CFU-GM. Cytological preparations of these progenitor colony
cultures after two weeks of growth showed cells with characteristics of myelocytes
(Fig.3), and promonocytes (Fig.4). Prolonged cultivation led to increased size of
most colonies and further maturation of the cells to the stage of band neutrophils
Figure 3. Myelocyte, or immature cell of granulocyte lineage, picked from a bone marrow CFU-GM
derived colony, day 14 of incubation. (May-Grunwald-Giemsa stain, magnification 100 x 10
x4)
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(Fig.5) and monocytes. Bone marrow CFU-GM derived colonies frequently had a
lot of fibroblasts.
Figure 4. Promonocyte. or Immature cell of monocyte lineage, picked from a bone marrow CFU-GM
derived colony, day 14 of incubation. (May-Grunwald-Giemsastain. magnification 1OOx1 0 x4)
Figure 5. Band neutrophils or immature cells of granulocyte lineage, picked from a bone marrow
CFU-GM derived colony, day 18 of incubation. (May-Grunwald-Giemsa stain, magnification
100x10x4)
The percentage of bone marrow and peripheral blood CFLJ-GM cells in S
phase of the cell cycle, as determined by the Ara-C suicide assay, was
approximately 34% and 22%, respectively (Table 3).
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Table 3. The percentageof pig bone marrowand peripheral blood







% in 8 phase
34.68 ± 4.60
22.15± 4.09
After incubation of cellswith orwithout Ara-C, bone marrowand peripheral blood CFU-
GMwere evaluated in cultures containing 1x105 cellswith 5% LCM and 1x106 with 10%
LCM, respectively. The percentage of progenitor cells in 8 phase was determined on
the basis of Ara-C suicide. The data are presented as the mean ± 8EM for 3-6
independent determinations.
DISCUSSION
Different animal models are necessary in studies of the hematopoietic
system in order to provide multiple information about the response of this system
in physiological and pathological conditions. The use of the pig as a large animal
model offers several advantages, and thus characterization of porcine bone
marrow and peripheral blood hematopoietic elements is needed in hematopoietic
research. The determination of CFU-GM is essential for various hematological
investigations, especially for stem cell transplantation and gene therapy.
In this study, the optimal culture conditions for the in vitro clonal assay for
pig CFU-GM progenitor cell growth were standardized based on dose-response
studies concerning determination of the optimal cell number plated and the
optimal concentration of homologous growth factors. This assay was used to
enumerate bone marrow and peripheral blood CFU-GM, as well as to determine
their proliferative activity.
The data obtained for the number of both bone marrow and peripheral blood
CFU-GM in pigs, as well as their mutual ratio, are in accordance with reports
concerning the values found for other animal species and man. The frequency of
bone marrow CFU-GM determined in our study was higher than corresponding
values reported for miniature swine of the same age (Emery et ai, 1996). As the
procedures for cultivation were similar, the relatively different results could be
ascribed to differences in the preparation of bone marrow cells. Emery et al (1996)
used unfractioned bone marrow cells, while we used a density gradient separated
population of light density mononuclear cells, among which the concentration of
myeloid progenitor cells was obviously higher.
As a source of homologous growth factors, pig leukocyte conditioned
medium LCM was used and its dose-dependent effects on CFU-GM growth
confirmed the presence of molecules that stimulate the proliferation and
differentiation of CFU-GM. Poor CFU-GM colony formation observed in cultures







:~('I""l"{':""n('"," with results reported for man nile'. (Liu
et et, 19S0, Tejero et el, 1989). The observed difference between the nc'rr""",",r"'!l~
of bone marrow and peripheral blood CFU-GM progenitor cells in
of the cells along with their different sensitivity to
conclusion peripheral blood contains a more nri,'"iti"c>
CFU-GM.
The results concerning the number and
bone marrov blood qranutocvte-macc: ;\ii:l~j::'
colony forrning on methytcellu.:»,«, Indicated that ttl '
pig CFU-GM proqe: cell r~"",partment is similar and comparaule
humans ano ,)(hd animals investigated,
Acknowledgments: The authors are thankful to the staff of H1e Institute for
animal-breeding and of the "Vizelj" pig farm for providing experimental animals;
to Mrs K. Bozanic, Mrs Z. Dlrnltrfjevic, Mrs M. Dokic and the veterinarian iliir V.
Hudina for technical assistance, This work was supported by grants from the
Ministry of Science and Technology of Serbia.
REFERENCES
1, Besinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, 1995, Transplantation of
allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte
colony-stimulating factor. Blood 23: 119-24.
2, Broxmeyer ne, Bognacki J, Ralph P, Dorner MH, Lu L, Castro-Malaspina f-I,1982,
Monocyte-macrophaqe derived acidic isoferritins: normal feedback requlators of
granuloGyte-macrophages progenitors. Blood 60:595,
24 Acta Veterinaria (Beograd), Vol. 51. No.1, 15-26, 2001.
Milica Kovacevic et. al. Pig bone marrow and peripheral blood granulocyte-macrophage
progenitor cells
3. Chikkappa G, Phillips PG and Brinson P, 1982, Differences in the sensitivity of normal human
peripheral blood and bone marrow granulocytic-macrophages and eosinophilic colony
forming cells to a source of colony stimulating factor. Exp Hematol, 10:852-8.
4. Chopra R, Goldstone AH, 1992, Modern trends in bone marrow transplantation for acute myeloid
and acute lymphoblastic leukemia, Curr Opp Oneal, 4,247.
5. Deldar A, Lewis H, Bloom J, Weiss L, 1988, Cephalosporin-induced alterations in erythroid (CFU··E)
and granulocyte macrophages (CFU-GM) colony forming capacity in canine bone marrow.
Fund Appl Toxicol, 11:450-63.
6. Demirer T, Weaver CH, Buckner CD et a/., 1995, High-dose cyclophosphamide, carmustine and
etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid
malignancies who received prior dose-limiting radiation therapy. J Clin Oneal 13:596.
7. Emery OW, Shafer EM, Karson EM, Sachs DH and Leguern C, 1992, Expression of allogeneic Class
II eDNA in swine bone marrow cells transduced with a recombinant retrovirus. Transpl Proc.24:
468-69.
8. Emery Ow, Shafer EM, Karson EM, Sachs DH and Leguern C, 1993, Retrovirus mediated transfer
and expression of allogeneic major histocompatibility complex class II DRB eDNA In swine
bone marrow cultures. Blood, 81: 2460-65
9. Emery OW, Sablinski T, Am JS, LeGuern C, Sachs Of-I, 1994, Bone marrow culture and transduction
of stem cells in a miniature swine model, Blood Cells, 20:498-503
10. Emery OW, Sach DH, LeGuern C. 1996, Culture and characterization of hematopoietic progenitor
cells from miniature swine. Exp Hemato/, 24, 927-35.
11. Fritsch G, Nelson RT. 1990, Bovine erythroid (CFU-E, BFU-E) and granulocyte-macrophage colony
formation in culture. Exp Hematol, 18, 195-200.
12. Geissler K, Valent P, Mayer P, Liehl E, Hinterberger W,LechnerK, Bettelheim P. 1990. Recombinant
human IL-3 expands the pool of circulating hematopoietic progenitor cells in
primates-synergism with recombinant human granulocyte/macrophage colony stimulating
factor. Blood, 75, 2305-10.
13. Goodman JW, Hodgson GS, 1962. Evidence for stem cells in the peripheral blood of mice. Blood
19,702-14.
14. Gordon MY. 1993, Human hematopoietic stem cell assays. Blood Reviews, 7, 1990-1997.
15. Gratwohl A, Hermans J. 1996, Allogeneic bone marrow transplantation for chronic myeloid
leukemia, Bone Marrow Transpl, 17, suppl.3, 7-9.
16. Gratwohl A, Baldomero H, John L, Gimmi C, Pless M, Tichelli A, Nissen C, Filipowicz A,1995,
Transplantation of G-CSF mobilized allogenic peripheral blood stem cells in rabbits. Bone
Marrow Transpl, 16, 63-8.
17. Guzzetta PC, Thoralf MS, Takao S, Mixon A, Rosengard BR, Sachs DH, 1991, Induction of kidney
transplantation tolerance across major histocompatibility complex barners by bone marrow
transplantation in miniature swine, Transpl, 51, 862-66.
18. Haig OM, Brown 0, Mackellar A, 1990, Ovine haernatopoiesis :the development of bone
marrow-derived colony-forming cells in vitro in the presence of factors derived from lymphoid
cells and helper T cells. Vetlmmunollmmunopathol.25: 125-137.
19. Irvine AE, French MA, Bridges JM, CrockardAD, Desai lR, Morris TCM, 1991, Normal unstimulated
lymphocytes produce granulopoietic inhibitory activity Exp Hematol, 19:106-109.
20. lvenovic Z, Petakov M.Jovcic G, Biljenovic-Psunovk: L, Balint B, Milenkovic P, 1997, Pluripotent
and committed haematopoietic progenitor cells in the rat peripheral blood. Camp Haematol
Intern 7, 1-6.
21. Kimura H, Finch CA, Adamson JW, 1986. Hematopoiesis in the rat: Quantification of hematopoietic
progenitors and the response to iron deficiency anemia. J Cell Physiol, 126, 298-306.
22. Kovacevic M, Boik: T, Pavlovic V, Petakov M, Bugarski 0, Jovcic G, lvenovic Z, 2000, Pig bone
marrow and peripheral blood erythroid progenitor cells in S phase of cell cycle. Acta Veterinaria
50,207-14.
23. Latinne 0, Vitiello OM, Sachs DH, Sykes M, 1994, Tolerance to discordant xenografls, Transplation,
57,238-45.
24. Liu YK, Stallard SS, Koo V, Dannaher CL, 1979, The proliferative states of circulating granulopoietic
stem cells in man. Scand J Haematol, 22: 258-62
25. Metcalf 0, 1984a, The hematopoietic colony stimulating factors (eds) Elsevier Sci Pub. BV. 39
26. Metcalf 0, 1984b, The hematopoietic colony stimulating factors (eds) Elsevier Sci Pub. BV. 234
27. Migliaccio G, Migliaccio AR, Adamson JW, 1990, The biology of hematopoietic growth factors:
studies in vitro under serum deprived conditions, Exp Hematol, 18:1049-55.
28. Murtaugh MP, 1994, Porcine cytokine. Vet Immunollmmunopath, 43:37-44.
29. Nothdurft W,Calvo W, Fleiner TM, Schnappauf HP, 1980, Investigation on the pool size, proliferative
state and differentiation pattern of splenic CFUc in normal dogs. Exp Hematol, 8: 988-95.
Acta Veterinaria (Beograd), Vol. 51. No.1, 15-26, 2001. 25
Milica Kovacevic et. al. Pig bone marrow and peripheral blood granulocyte-macrophage
progenitor cells
30, Pantel K,Nakeff A, 1993, The role of lymphoid cells in hematopoietic regulation, Exp Hemato/,
21:738-42.
3/. Pless M, Wodnar-Filipowicz A. John., Baldomero H, Lyman SO,Nissen C, GratwohlA, 1999, Synergy
of growth factors during mobilization of peripheral blood precursor cells with recombinant
human Flt-3 and granulocyte colony-stimulating factor in rabbits. Exp Hemato/, 27: 1155-61.
32. Robertson MJ, Soiffer RJ, Freedman AS et a/., 1992, Human bone marrow depleted of CD33+ cells
mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal
antibody-purged autografts for the treatment of acute myeloid leukemia. Blood, 79:2229-36.
33, Ruvidi6 R, Jovcic G, Biljanovi6-Paunovi6, Stojanovi6 N, Mijovi6 A, Pavlovi6-Kentera V, 1985,
Myelopoiesis and erythropoiesis of bone marrow cells cultured in vitro in patients recovered
from aplastic anemia. Scand J Haematol .35:437-44,
34. Saalmuller A, 1996. Characterization of swine leukocyte differentiation antigen. Immunol Tod, 17,
352-4.
35. Scneidkraut MJ, Hangoc G, Bender JG, Hutenburg CC, 1996, The contribution of animal models
to the development of treatments for hematologic recovery following myeloablative therapy: A
review, J Hematoth, 5: 631-46.
36. Shulman LN, Robinson SH, 1980, Roles of CFU-S and CFU-C in maintaining cell growth in diffusion
chamber cultures in murine marrow. In: Cronkite EP, Carsten AL (eds) Diffusion chamber
culture, Berlin:Springer, 11,
37. Srour EF. Hoffman R, Zanjani ED, 1992, Animal models for human hematopoiesis, J Hematother. 1:
143-53.
38. Standen G. Philip MA. Fletcher J. 1980, The proliferative state of granulocyte progenitor cells in
human blood and marrow. Cell Tiss Kinet 13, 105-13,
39. Summerfield A, McCullough KC, 1997, Porcine bone marrow myeloid cells: phenotype and
adhesion molecule expression. J Leuk Bioi, 62, 176-85,
40. Sykes M, 1996, Hematopoietic cell transplantation for the induction of allo- and xenotolerance, Clin
Trenspl, 10, 357-363.
41. Takamatsu Y, Harada M, Teshima T et el, 1995, Relationship of infused CFU-GM and CFU-Mk
mobilized by chemotherapy with and without G-CSF to platelet recovery after autologous blood
stem cell transplantation. Exp Hematol, 23: 18-23,
42. Tejero C, Testa NG, Hendry JH, 1989, Decline in cycling of granulocyte-macrophage colony forming
cells with increasing age in mice. Exp Hematol, 17:66-7.
43. Tilly H, Charbord P, Morardet N, Parmentier C, 1986, Normal human serum stimulating activity on
granulocyte-macrophage colony formation in vitro Int J Cell Cloning,4: 63-8.
44. Tumbleson ME, Schook LB, 1996, In: Advances in Swine Biomedical Research ed. Tumbleson and
Schook, Plenum Press, New York, 1-4.
45. Utsumi M, Hoffa T, Mutate T, Kato T, Yamada H, 1984, Maturation sequence hierarchy of murine
macrophage progenitor cells. Exp Hematol, 12:83-90,
MATICNE CELIJE OPREDELJENE ZA GRANULOCITNO-MONOCITNU LOZU KOSTNE SRZII
PERIFERNE KRVI SVINJA
KOVACEVIC MILlCA, BOZIC TATJANA, JOVCIC GORDANA, PETAKOV MARIJANA, BUGARSKI
DIANA, STANKOVIC JELENA i IVANOVIC Z.
SADRZAJ
Svinja je zivotinia koja se koristi kao model u razlicitirn biomedicinskim
istrazivanjirna, a mogla bi biti i interesantan model u ispitivanju fiziologije i
patolofizioloskih promena hematopoetskog sistema. U cilju razvoja
eksperimentalnog modela svinje u istrazivanju hematopoeze, stanadardizovan je
esej za odredivanje i karakterizaciju opredeljenih rnaticnih 6elija
granulocitno-monocitne loze iz kostne srzi i krvi odrasle svinje. Stimulacija
proliferacije i diferencijacije ovih rnaticnih celi]a postignuta je dodavanjem
medijuma kondicioniranog leukocitima (LCM - Leukocyte conditioned medium)
bogatog faktorima rasta. Broj CFU-GM (Colony forming unit-
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granulocyte-macrophage) je direktno zavisio od koncentracije LCM-a. Procenat
CFU-GM 6elija u S fazi 6elijskog ciklusa odredjivan je tehnikorn "suicida"
koriscenjern citozin arabinozida (Ara-C) i iznosio ]e 34,7% za CFU-GM iz kostne
srzi i 22.2% za CFU-GM iz periferne krvi. Podaci dobijeni za braj i karakteristike
CFU-GM iz kostne srzi i periferne krvi potvrduju da je ovaj odeljak rnaticnih 6elija
kod odraslih svinja organizovan na isti nacin kao i kod minijaturnih svinja, drugih
vrsta zivotinja i Ijudi.
